Corporate News 19-Jul-23
Shivalik Rasayan authorises Medicamen Biotech to use DMF grade Bortezomib API
Shivalik Rasayan has issued LOA (Letter of Authorisation) to Medicamen Biotech, to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial.
Medicamen Biotech has filed its first ANDA with USFDA today.
Previous News
Shivalik Rasayan consolidated net profit rises 15.24% in the December 2021 quarter
( Results - Announcements 09-Feb-22 08:13 )
Shivalik Rasayan to hold board meeting
( Corporate News - 30-May-23 18:54 )
Medicamen Biotech announces board meeting date
( Corporate News - 03-Feb-22 11:09 )
Shivalik Rasayan consolidated net profit rises 167.73% in the June 2021 quarter
( Results - Announcements 14-Aug-21 07:59 )
Shivalik Rasayan consolidated net profit rises 42.80% in the September 2019 quarter
( Results - Announcements 12-Nov-19 10:50 )
Medicamen Biotech to convene board meeting
( Corporate News - 26-Sep-22 10:37 )
Shivalik Rasayan to hold AGM
( Corporate News - 16-Sep-22 16:17 )
Shivalik Rasayan announces board meeting date
( Corporate News - 04-Aug-22 12:49 )
Divis Laboratories Ltd Slips 7.72%, S&P BSE Healthcare index Shed 1.43%
( Hot Pursuit - 08-Nov-21 09:45 )
Medicamen Biotech signs CDMO agreement with Vital Pharma Nordic
( Corporate News - 12-Aug-22 16:16 )
Shivalik Rasayan
( Results - Analysis 01-Jul-20 19:05 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
